Discover 156 paid clinical trials in College Station, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 156
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
for
Attention Deficit Disorder With Hyperactivity (ADHD)
Location: The Woodlands TX, Austin TX, Little Rock AR, Lincoln NE,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 65
Code: NCT07755410
Phase 2, Recruiting
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
for
Inflammatory Breast Carcinoma, Invasive Breast Carcinoma,
Location: The Woodlands TX, Houston TX, Sugar Land TX,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT00477100
Recruiting
Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
for
Breast Ductal Carcinoma In Situ, COVID-19 Infection,
Location: Conroe TX, Sugar Land TX, Houston TX, League City TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT04169542
Recruiting
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: Conroe TX, Houston TX, Sugar Land TX, League City TX,
Sponsor: NRG Oncology
Sex: Female
Age: 18+
Code: NCT06388018
Phase 2, Recruiting
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
for
Oropharyngeal Cancer
Location: Conroe TX, Houston TX, Sugar Land TX, League City TX,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT05451004
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
for
Locally Advanced or Metastatic ER+ HER2- Breast Cancer,
Location: Conroe TX, Houston TX, Sugar Land TX, League City TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT04606446
Phase 2, Recruiting
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
for
Peritoneal Malignant Mesothelioma
Location: Conroe TX, Houston TX, Sugar Land TX, League City TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05001880
Phase 2, Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for
Breast Cancer
Location: Conroe TX, Houston TX, Waco TX, Sugar Land TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07062965
Phase 3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Conroe TX, Temple TX, Houston TX, Sugar Land TX,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07097142
Phase 3, Recruiting
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
for
Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-),
Location: Conroe TX, Sugar Land TX, Houston TX, League City TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07318805
Phase 1, Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Conroe TX, The Woodlands TX, Cypress TX, Houston TX,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase 3, Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
for
Buccal Mucosa Squamous Cell Carcinoma,
Location: Conroe TX, Houston TX, Sugar Land TX, League City TX,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT04333537
Phase 2, Phase 3, Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Houston TX, Aurora CO, Tampa FL, Jacksonville FL,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase 2, Phase 3, Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: Conroe TX, Sugar Land TX, Houston TX, League City TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07090499
Phase 1, Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Location: Conroe TX, The Woodlands TX, Cypress TX, Houston TX,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06958328
Phase 3, Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Conroe TX, The Woodlands TX, Houston TX, Humble TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07144280
Phase 3, Recruiting
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
for
Acute Promyelocytic Leukemia With PML-RARA
Location: The Woodlands TX, Houston TX, Sugar Land TX,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 10+
Code: NCT01409161
Phase 2, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Conroe TX, Houston TX, Sugar Land TX, League City TX,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase 3, Recruiting
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
for
Castration-Resistant Prostate Carcinoma,
Location: Conroe TX, Houston TX, Sugar Land TX, League City TX,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT06470243
Phase 3, Recruiting
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
for
Castration Levels of Testosterone,
Location: Conroe TX, Houston TX, Sugar Land TX, League City TX,